A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Semaglutides, which are sold under the brand name Ozempic, help persons with type 2 diabetes manage their blood ... Glucose Monitoring (CGM) systems. Its wearable devices, like the Dexcom G6 ...

The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Non-Invasive Blood Glucose Monitoring Devices Market was valued US$ 24.3 Mn in 2025 and is expected to reach US$ 68.3 Mn by 2032 growing at a CAGR of 15.9%. BURLINGAME, CA, UNITED STATES ...

Dexcom is a leader in the continuous glucose monitor space, which are vital tools for people managing diabetes, offering discreet, wearable sensors that allow users to track their blood sugar ...

DexCom Option Volume And Open Interest Over ... CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide ...